analyzeportfolio
Nasdaq · Consumer Discretionary

Petco Health & Wellness Company, Inc. (WOOF)

As-reported financials and SEC filings for Petco Health & Wellness Company, Inc. The latest annual period is FY2025. The latest reported quarter is Q1 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Petco Health & Wellness Company, Inc.

Petco Health & Wellness Company, Inc. is a pet specialty retailer that offers pet products, services, and veterinary care through approximately 1,400 pet care centers in the United States and Puerto Rico, as well as locations in Mexico and Chile. The company sells a wide range of pet nutrition and supplies, including national and owned brands, and provides services such as veterinary care, grooming, and training. Petco serves pet owners by integrating in-store and digital channels to offer convenient shopping and care options.

Snapshot

Revenue
$5.96B
Revenue growth (YoY)
-2.5%
Net income
$9.1M
Diluted EPS
$0.03
Gross margin
38.7%
Operating margin
2.0%
Net margin
0.2%
FCF margin
3.1%
ROE
0.8%
net income / fiscal-year-end equity
P/E
129.0×
trailing when available, otherwise FY EPS
Market cap
$736.8M
Long-term debt / equity
1.28×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended January 31, 2026). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Petco Health & Wellness

  • Revenue fell 2.5% to $6.0B in FY2025, after a 2.2% decline the year before.
  • Operating margin is 2.0% in FY2025, -2.6 pp against 4.6% in FY2021.
  • Most recent quarter Q1 FY2026: revenue $1.5B, up 0.2% from Q1 FY2025.
  • Free cash flow was $187M in FY2025, 3.1% of revenue.
  • Net income turned positive at $9M in FY2025, from a $102M loss in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Petco Health & Wellness’s fundamentals sit among the 403 Consumer Discretionary companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin38.7%
57th percentile of 275
Operating margin2.0%
41st percentile of 348
Net margin0.2%
34th percentile of 377
FCF margin3.1%
43rd percentile of 351
Revenue growth (YoY)-2.5%
29th percentile of 394
ROE0.8%
35th percentile of 343
P/E129.0×
97th percentile of 249
Long-term debt / equity1.28×
77th percentile of 234
Short interest13.03d
96th percentile of 401

Petco Health & Wellness’s P/E of 129.0 ranks in the 97th percentile of the 249 peers with a meaningful P/E.

No reported insider purchases (code P) in the last 90 days; 3 insider sales totaling $1.1M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 1 of the superinvestors we track (plus 5 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
1
+5 quant / multi-strat
Initiated / added
1
0 new, 1 added
Reduced / exited
7
5 trimmed, 2 exited
Combined position
$24.4M
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$15.2M5.6MReduced
AQR Capital ManagementquantQ2 2026$4.3M1.6MReduced
Renaissance TechnologiesquantQ2 2026$2.1M753.9KAdded
D. E. ShawquantQ2 2026$1.7M636.2KReduced
Gotham Asset ManagementQ2 2026$659,401242.4KReduced
Point72 Asset ManagementquantQ2 2026$417,022153.3KReduced

No longer held by: Citadel Advisors (as of Q2 2026), Millennium Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
3
$1.1M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-07-09
filed 2026-07-10
May HollyChief Human Resources OfficerSell200.0K$2.54$508K
2026-07-08
filed 2026-07-09
May HollyChief Human Resources OfficerSell150.0K$2.55$383K
2026-07-07
filed 2026-07-09
May HollyChief Human Resources OfficerSell100.0K$2.55$255K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
19.5M
settled 2026-08-14
Change vs prior
-0.4%
vs previous settlement
Days to cover
13.03
at avg daily volume
Avg daily volume
1.5M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-1419.5M-0.4%13.03
2026-07-3119.6M-0.7%14.27
2026-07-1519.7M+1.3%13.11
2026-06-3019.5M+3.0%8.69
2026-06-1518.9M+3.9%5.83
2026-05-2918.2M+3.8%11.32
2026-05-1517.5M+1.1%10.24
2026-04-3017.3M+0.9%13.88

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$5.96B$6.12B$6.26B$6.04B$5.81B
Gross profit$2.31B$2.32B$2.35B$2.43B$2.43B
Operating income$120.4M$7.1M$-1.18B$225.6M$266.1M
Net income$9.1M$-101.8M$-1.28B$90.8M$164.4M
Diluted EPS$0.03$-0.37$-4.78$0.34$0.62

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$314.1M$177.7M$215.7M$346.0M$358.2M
Capital expenditure$127.1M$128.0M$225.6M$278.0M$239.1M
Free cash flow$187.0M$49.7M$-9.9M$68.0M$119.1M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q1 FY2026$1.50B0.2%$-15.1M$-0.05
Q4 FY2025$1.52B-2.4%$-2.6M$-0.01
Q3 FY2025$1.46B-3.1%$9.3M$0.03
Q2 FY2025$1.49B-2.3%$14.0M$0.05
Q1 FY2025$1.49B-2.3%$-11.7M$-0.04
Q4 FY2024$1.55B-7.3%$-13.8M$-0.05
Q3 FY2024$1.51B1.2%$-16.7M$-0.06
Q2 FY2024$1.52B-0.5%$-24.8M$-0.09

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorConsumer Discretionary
SIC industryRetail-Retail Stores, NEC
Latest annual periodFY2025 (ended January 31, 2026)
Latest reported quarterQ1 FY2026 (ended May 2, 2026)
Oldest indexed filing2020
SEC CIK1826470

Selected SEC filings

10-K2026-03-13
View on EDGAR →
10-Q2026-06-05
View on EDGAR →
10-Q2025-12-05
View on EDGAR →
8-K2026-08-03
View on EDGAR →
8-K2026-07-17
View on EDGAR →
8-K2026-07-01
View on EDGAR →
8-K2026-06-03
View on EDGAR →

Largest Consumer Discretionary peers

All Consumer Discretionary companies →

Monitor WOOF

Get an alert when Petco Health & Wellness files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor WOOF free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.